Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study

BACKGROUND: The purpose of this study was to evaluate the activity of Selective Inhibitors of Nuclear Export (SINE) compounds that inhibit the function of the nuclear export protein Exportin 1 (XPO1/CRM1) against canine tumor cell lines and perform a Phase I clinical trial of KPT-335 in dogs with sp...

Descripción completa

Detalles Bibliográficos
Autores principales: London, Cheryl A., Bernabe, Luis Feo, Barnard, Sandra, Kisseberth, William C., Borgatti, Antonella, Henson, Mike, Wilson, Heather, Jensen, Kiersten, Ito, Daisuke, Modiano, Jaime F., Bear, Misty D., Pennell, Michael L., Saint-Martin, Jean-Richard, McCauley, Dilara, Kauffman, Michael, Shacham, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913620/
https://www.ncbi.nlm.nih.gov/pubmed/24503695
http://dx.doi.org/10.1371/journal.pone.0087585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913620/
https://www.ncbi.nlm.nih.gov/pubmed/24503695
http://dx.doi.org/10.1371/journal.pone.0087585

Ejemplares similares